Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 33,184Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Azacitidine For Injection

02 1Azacitidine for Injection

03 1Azacitidine for injection

04 1Kyprolis

05 4Onureg

06 5Vidaza

07 3Vidaza

08 1Vidaza - BMS

09 1Vidaza - Celgene

10 1azacitidine for Injection

PharmaCompass

01

Brand Name : Onureg

Azacitidine

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Brand Name : Onureg

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Azacitidine

Main Therapeutic Indication : Oncology

Currency : USD

2020 Revenue in Millions : 17

2019 Revenue in Millions : 0

Growth (%) : New Launch

blank

02

Brand Name : Vidaza

Azacitidine

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Brand Name : Vidaza

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Azacitidine

Main Therapeutic Indication : Oncology

Currency : USD

2020 Revenue in Millions : 455

2019 Revenue in Millions : 521

Growth (%) : -13

blank

03

Brand Name : Onureg

Azacitidine

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Brand Name : Onureg

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Azacitidine

Main Therapeutic Indication : Oncology

Currency : USD

2021 Revenue in Millions : 73

2020 Revenue in Millions : 17

Growth (%) : 329

blank

04

Brand Name : Vidaza

Azacitidine

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Brand Name : Vidaza

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Azacitidine

Main Therapeutic Indication : Oncology

Currency : USD

2021 Revenue in Millions : 22

2020 Revenue in Millions : 33

Growth (%) : -35

blank

05

Brand Name : Onureg

Azacitidine

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Brand Name : Onureg

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Azacitidine

Main Therapeutic Indication : Oncology

Currency : USD

2022 Revenue in Millions : 124

2021 Revenue in Millions : 73

Growth (%) : 70

blank

06

Brand Name : Vidaza

Azacitidine

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Brand Name : Vidaza

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Azacitidine

Main Therapeutic Indication : Oncology

Currency : USD

2022 Revenue in Millions : 16

2021 Revenue in Millions : 22

Growth (%) : -26

blank

07

Brand Name : Onureg

Azacitidine

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Brand Name : Onureg

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Azacitidine

Main Therapeutic Indication : Oncology

Currency : USD

2023 Revenue in Millions : 168

2022 Revenue in Millions : 124

Growth (%) : 35

blank

08

Brand Name : Kyprolis

Azacitidine

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Brand Name : Kyprolis

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Azacitidine

Main Therapeutic Indication : Oncology

Currency : USD

2023 Revenue in Millions : 15

2022 Revenue in Millions : 16

Growth (%) : -8

blank

09

Brand Name : Vidaza

Azacitidine

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Brand Name : Vidaza

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Azacitidine

Main Therapeutic Indication : Oncology

Currency : USD

2015 Revenue in Millions : 612

2014 Revenue in Millions : 591

Growth (%) : -3%

blank

10

Brand Name : Azacitidine for injection

Azacitidine

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Brand Name : Azacitidine for injection

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Azacitidine

Main Therapeutic Indication :

Currency : USD

2015 Revenue in Millions : 78

2014 Revenue in Millions : 84

Growth (%) : 8%

blank